81
14. Maruyama, R., Toyooka, S., Toyooka, K. O., Virmani, A. K., Zochbauer-Muller, S.,
Farinas, A. J. et al.: Aberrant promoter methylation profile of prostate cancers and its
relationship to clinicopathological features. Clin Cancer Res, 8: 514, 2002
15. Nakayama, T., Watanabe, M., Yamanaka, M., Hirokawa, Y., Suzuki, H., Ito, H. et al.:
The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in
human prostate cancers. Lab Invest, 81: 1049, 2001
16. Caldeira, J. R., Prando, E. C., Quevedo, F. C., Neto, F. A., Rainho, C. A., Rogatto, S.
R.: CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating
breast cancer. BMC Cancer, 6: 48, 2006
17. Negraes, P. D., Favaro, F. P., Camargo, J. L., Oliveira, M. L., Goldberg, J., Rainho, C.
A. et al.: DNA methylation patterns in bladder cancer and washing cell sediments: a
perspective for tumor recurrence detection. BMC Cancer, 8: 238, 2008
18. Livak, K. J., Schmittgen, T. D.: Analysis of relative gene expression data using real-
time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25: 402, 2001
19. Yoshimoto, M., Joshua, A. M., Cunha, I. W., Coudry, R. A., Fonseca, F. P., Ludkovski,
O. et al.: Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is
associated with a favorable outcome. Mod Pathol, 21: 1451, 2008
20. De Marzo, A. M., Marchi, V. L., Yang, E. S., Veeraswamy, R., Lin, X., Nelson, W. G.:
Abnormal regulation of DNA methyltransferase expression during colorectal
carcinogenesis. Cancer Res, 59: 3855, 1999
21. Kwabi-Addo, B., Chung, W., Shen, L., Ittmann, M., Wheeler, T., Jelinek, J. et al.: Age-
related DNA methylation changes in normal human prostate tissues. Clin Cancer Res,
13: 3796, 2007
22. Mehrotra, J., Varde, S., Wang, H., Chiu, H., Vargo, J., Gray, K. et al.: Quantitative,
spatial resolution of the epigenetic field effect in prostate cancer. Prostate, 68: 152,
2008
23. Aitchison, A., Warren, A., Neal, D., Rabbitts, P.: RASSF1A promoter methylation is
frequently detected in both pre-malignant and non-malignant microdissected prostatic
epithelial tissues. Prostate, 67: 638, 2007
24. Lotan, Y., Xu, X. C., Shalev, M., Lotan, R., Williams, R., Wheeler, T. M. et al.:
Differential expression of nuclear retinoid receptors in normal and malignant prostates.
J Clin Oncol, 18: 116, 2000
25. Richter, F., Joyce, A., Fromowitz, F., Wang, S., Watson, J., Watson, R. et al.:
Immunohistochemical localization of the retinoic Acid receptors in human prostate. J
Androl, 23: 830, 2002
26. Sommer, K. M., Chen, L. I., Treuting, P. M., Smith, L. T., Swisshelm, K.: Elevated
retinoic acid receptor beta(4) protein in human breast tumor cells with nuclear and
cytoplasmic localization. Proc Natl Acad Sci U S A, 96: 8651, 1999